Xylazine for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Xylazine is a prescription alpha-2 adrenergic agonist your vet may use to provide sedation, short-term pain control, and muscle relaxation in horses. In the U.S., labeled equine use is 0.5 mg/lb IV or 1.0 mg/lb IM to produce sedation, provide analgesia, and serve as a preanesthetic before local or general anesthesia. It is a short-acting drug compared with some other equine sedatives, which is one reason vets often choose it for brief procedures.

In practical terms, xylazine helps a horse become calmer, lower the head, and tolerate handling more safely. That can make procedures like oral exams, dental work, wound treatment, lameness imaging, and catheter placement easier for both the horse and the veterinary team.

This medication should only be given by or on the order of your vet. Route, dose, and whether it is used alone or combined with another drug depend on the horse's age, temperament, pain level, heart and lung status, pregnancy status, and the type of procedure planned.

Your vet may use xylazine for standing sedation, short-term analgesia, and as a preanesthetic before local blocks or general anesthesia. It is commonly chosen when a horse needs to stand quietly for a brief exam or procedure but does not need full anesthesia.

Common examples include dental floating, oral exams, radiographs, ultrasound, wound cleaning or suturing, sheath or udder exams, bandage changes, and some minor field procedures. In emergency settings, your vet may also use it to help control pain and improve handling during initial stabilization.

Xylazine is also frequently combined with other medications. For example, your vet may pair it with butorphanol for deeper sedation and better analgesia, or use it before ketamine when inducing short general anesthesia. Those combinations can be very useful, but they also increase the need for close monitoring.

Xylazine dosing in horses is not one-size-fits-all. The labeled U.S. equine dose is 0.5 mg/lb IV or 1.0 mg/lb IM, which is about 1.1 mg/kg IV or 2.2 mg/kg IM. Many equine vets also use lower IV doses for standing sedation, then titrate to effect based on the horse's response, the procedure, and whether other sedatives or opioids are being added.

The route matters. IV dosing acts faster and is easier for your vet to fine-tune. IM dosing may be used when IV access is not practical, but onset is slower and recovery can be less predictable. Xylazine is usually considered a short-acting sedative in horses, with useful sedation often lasting roughly 20 to 30 minutes, though that varies with dose, route, excitement level, and drug combinations.

Because xylazine can affect heart rate, blood pressure, breathing, gut motility, and coordination, pet parents should never try to calculate or give this drug on their own. Your vet may adjust the plan for foals, geriatric horses, horses with colic, horses with heart rhythm issues, pregnant mares, or horses already receiving other sedatives, anesthetics, or pain medications.

Common and expected effects include sleepiness, lowered head carriage, droopy lips, reduced responsiveness, and ataxia. Many horses also show a slower heart rate, and partial second-degree AV block can occur during sedation. Mild respiratory depression may occur as well. Some horses sweat as the sedation wears off.

Other reported effects include muscle tremors, increased urination, decreased gut motility, and sensitivity to sudden sound or touch even while sedated. Because coordination is reduced, there is always some risk of stumbling, leaning, or becoming unsafe to handle if the environment is not controlled.

See your vet immediately if your horse has marked weakness, collapse, severe breathing difficulty, prolonged recovery, extreme agitation, worsening colic signs, or any reaction that seems stronger than expected. Extra caution is important in horses with cardiovascular disease, shock, dehydration, respiratory compromise, suspected ileus or obstructive colic, and in late-pregnant mares.

Xylazine can have additive sedative and cardiopulmonary effects when combined with other central nervous system depressants. That includes drugs such as butorphanol, morphine, diazepam, midazolam, ketamine, acepromazine, and inhalant anesthetics. These combinations are common in equine practice, but they require dose adjustments and active monitoring by your vet.

Because xylazine can slow the heart and alter blood pressure, your vet will also be cautious in horses receiving other drugs that affect cardiovascular function. Horses with preexisting bradycardia, conduction abnormalities, poor perfusion, or significant systemic illness may need a different sedation plan.

Xylazine may also reduce gastrointestinal motility, so your vet may avoid or modify its use in horses with certain colic presentations or suspected ileus. In pregnant mares, caution is warranted because alpha-2 agonists can affect uterine tone. Always tell your vet about every medication, supplement, and recent sedative your horse has received before any procedure.